The Intravesical Bladder Cancer Therapeutics Market a critical segment within the broader oncology landscape, focuses on treatments administered directly into the bladder. This method is primarily used for non-muscle-invasive bladder cancer (NMIBC), which accounts for a significant portion of all bladder cancer cases. The market is driven by the high recurrence rate of NMIBC and the n... https://www.databridgemarketresearch.com/